EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Hepatorenal Syndrome—Novel Insights into Diagnostics and Treatment

Krzysztof Badura iD, Weronika Frąk iD, Joanna Hajdys iD, Gabriela Majchrowicz iD, Ewelina Młynarska iD, Jacek Rysz, Beata Franczyk

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242417469 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Krzysztof Badura und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrocardiology, Medical University of Lodz, Ul. Zeromskiego 113, 90-549 Lodz, Poland. Hauptthemen laut MEDLINE: Hepatorenal Syndrome, Liver Transplantation, Acute Kidney Injury. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 260 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatorenal syndrome (HRS) is a disorder associated with cirrhosis and renal impairment, with portal hypertension as its major underlying cause. Moreover, HRS is the third most common cause of acute kidney injury, thus creating a major public health concern. This review summarizes the available information on the pathophysiological implications of HRS. We discuss pathogenesis associated with HRS. Mechanisms such as dysfunction of the circulatory system, bacterial infection, inflammation, impaired renal autoregulation, circulatory, and others, which have been identified as critical pathways for development of HRS, have become easier to diagnose in recent years. Additionally, relatively recently, renal dysfunction biomarkers have been found indicating renal injury, which are involved in the pathophysiology of HRS. This review also summarizes the available information on the management of HRS, focusing on vasoconstrictive drugs, renal replacement therapy, and liver transplant together with currently being investigated novel therapies. Analyzing new discoveries for the underlying causes of this condition assists the general research to improve understanding of the mechanism of pathophysiology and thus prevention of HRS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatorenal SyndromeLiver TransplantationAcute Kidney InjuryHumansKidneyLiver CirrhosisVasoconstrictor Agents

Stichwörter der Autor:innen

acute kidney injurybiomarkerscirrhosishepatorenal syndromeliver transplantationnovel therapiespathophysiologyvasoconstrictor drugs

Substanzen

Vasoconstrictor Agents

Autor:innen und Institutionen

  • Department of Nephrocardiology, Medical University of Lodz, Ul. Zeromskiego 113, 90-549 Lodz, Poland.
  • Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, Ul. Zeromskiego 113, 90-549 Lodz, Poland.

ORCID-Profile: Krzysztof Badura, Weronika Frąk, Joanna Hajdys, Gabriela Majchrowicz, Ewelina Młynarska

Zitieren

APA

Badura, K., Frąk, W., Hajdys, J., Majchrowicz, G., Młynarska, E., Rysz, J., & Franczyk, B. (2023). Hepatorenal Syndrome—Novel Insights into Diagnostics and Treatment. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242417469

Vancouver

Badura K, Frąk W, Hajdys J, Majchrowicz G, Młynarska E, Rysz J, et al. Hepatorenal Syndrome—Novel Insights into Diagnostics and Treatment. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242417469

BibTeX
@article{Badura2023,
  author = {Badura, Krzysztof and Frąk, Weronika and Hajdys, Joanna and Majchrowicz, Gabriela and Młynarska, Ewelina and Rysz, Jacek and Franczyk, Beata},
  title = {Hepatorenal Syndrome—Novel Insights into Diagnostics and Treatment},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242417469}
}
Kostenlos starten →